March 24, 2026
If you’ve ever watched a promising biotech stock cut in half despite no bad news, only to find a prospectus supplement filed the next morning, you’ve experienced the most common phenomenon in biotech investing. Dilution isn’t a bug in the biotech model — it’s a structural feature that any investor in the sector needs to […]
Read More →Stock dilution happens when a company issues new shares, reducing the ownership percentage of every existing shareholder. If a company has 10 million shares and issues 2 million new ones, your slice of the pie just got smaller — and the price usually follows. For large-cap investors, dilution is a minor concern. For small-cap and […]
Read More →